CITrials COVID-19 Update

We at CiTrials are continually up to date with our local, state, and federal health guidelines so that our daily activities including but not limited to volunteer visits, on-site services, study medications, supplies, and labs are not impacted.
As more of our counties open, more clinical studies are also open for participation. Our volunteers’ safety is our number priority as they enroll into studies. Our health care staff continue to follow strict safety requirements including checking body temperature, wearing of masks and social distancing for all our volunteers at our clinics in Bellflower, Santa Ana and Riverside. 
We want to thank our volunteers for dedicating their time to help the medical community advance medical research for the benefit of our fellow citizens. And a huge thank you to all the health care workers for keeping everyone safe. Mask On. Live On

The International Society for CNS Clinical Trials and Methodology

The International Society for CNS Clinical Trials and Methodology

CITrials COVID-19 Update

CITrials has contingency measures implemented to manage conducting clinical trials during COVID-19 – our teams + rate is currently 0%.

We will be open from 8:30 am to 7:00 pm, Monday through Sunday so that our volunteers can come into office with less stress and less total people!

The International Society for CNS Clinical Trials and Methodology

The International Society for CNS Clinical Trials and Methodology

The International Society for CNS Clinical Trials and Methodology (ISCTM) held its annual conference this month at the Grand Hyatt in Washington D.C. The four day event covered everything in the field of CNS clinical trials, from neuroscience drug development to brain-gut axis in psychiatry and neurology. This year’s society meeting had an emphasis on the use of artificial intelligence and machine learning within the world of clinical trials. CiTrials CEO and conference attendee Debra Hoffmeyer, speaking on the subject, stated that the growing technology of AI could benefit the industry in numerous ways and optimize the process of drug development immensely. Hoffmeyer, new elect Chair of Membership Committee also sits on the Finance Committee of the ISCTM. 

The International Society for CNS Clinical Trials and Methodology (ISCTM) is a multi-disciplinary independent organization, devoted to promoting advances that address strategic clinical, regulatory, methodological and policy challenges that arise in the development and use of CNS therapeutic agents. This work is accomplished through partnership with persons in academia, industry, government, policy-making, and the public. Focus in CNS in areas, schizophrenia, depression, bipolar, personality disorder, alzheimers and cognition clinical trials.